Collegium Pharmaceutical (COLL) Shares Outstanding (Weighted Average) (2014 - 2026)

Collegium Pharmaceutical's Shares Outstanding (Weighted Average) history runs 13 years deep, the most recent figure standing at $32.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 0.92% year-over-year to $32.1 million; the TTM figure through Mar 2026 stood at $32.1 million (up 0.92% YoY), while the FY2025 annual figure was $31.7 million, down 1.76% from the prior year.
• Shares Outstanding (Weighted Average) was $32.1 million for Q1 2026 at Collegium Pharmaceutical, up from $31.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $34.6 million in Q2 2023 to a low of $31.6 million in Q3 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $33.0 million across 5 years, with a median of $32.4 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) rose 1.92% in 2023, then retreated 6.32% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $33.8 million in 2022, then fell by 0.26% to $33.7 million in 2023, then decreased by 4.35% to $32.3 million in 2024, then decreased by 1.76% to $31.7 million in 2025, then advanced by 1.2% to $32.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $32.1 million (Q1 2026), $31.7 million (Q4 2025), and $31.6 million (Q3 2025), per Business Quant data.